Mitchell Diccianni

2PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 15, 2022
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.

Ami V Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak

|Jul 23, 2020
Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO.

Mitchell B Diccianni, Katarzyna Kempińska, Jon A Gangoti

Pageof 1